{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:54:39Z","timestamp":1792079679041,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023J01614"],"award-info":[{"award-number":["2023J01614"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023J05138"],"award-info":[{"award-number":["2023J05138"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cyto.2026.157113","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T12:49:25Z","timestamp":1768049365000},"page":"157113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["IL-6 trans-signaling activates the TGF-\u03b2 pathway via soluble factors in difficult-to-treat rheumatoid arthritis joint fluid"],"prefix":"10.1016","volume":"199","author":[{"given":"Yang","family":"Bei-bei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Ji-zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hong-bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2026.157113_bb0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","article-title":"Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions","volume":"18","author":"Komatsu","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2026.157113_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2026.157113_bb0015","first-page":"253","article-title":"Unusual findings in synovial fluid analysis: a review","volume":"47","author":"Oliviero","year":"2017","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.cyto.2026.157113_bb0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3899\/jrheum.141292","article-title":"Upregulation of thrombospondin 1 expression in synovial tissues and plasma of rheumatoid arthritis: role of transforming growth factor-beta1 toward fibroblast-like synovial cells","volume":"42","author":"Suzuki","year":"2015","journal-title":"J. Rheumatol."},{"issue":"Pt 2","key":"10.1016\/j.cyto.2026.157113_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3000281","article-title":"Soluble receptors for cytokines and growth factors: generation and biological function","volume":"300","author":"Rose-John","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.cyto.2026.157113_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155577","article-title":"Therapeutic targeting of IL-6 trans-signaling","volume":"144","author":"Rose-John","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2026.157113_bb0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.182.1.613","article-title":"Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis","volume":"182","author":"Nowell","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2026.157113_bb0040","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.171.6.3202","article-title":"Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130","volume":"171","author":"Nowell","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2026.157113_bb0045","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/art.21818","article-title":"Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis","volume":"54","author":"Richards","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2026.157113_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-0716-3331-1_16","article-title":"Dissecting Interleukin-6 classic and trans-signaling in inflammation and Cancer","volume":"2691","author":"Garbers","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cyto.2026.157113_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120516","article-title":"Underpinning IL-6 biology and emphasizing selective JAK blockade as the potential alternate therapeutic intervention for rheumatoid arthritis","volume":"298","author":"Srivastava","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.cyto.2026.157113_bb0060","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.2147\/DDDT.S99696","article-title":"Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis","volume":"10","author":"Sakkas","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.cyto.2026.157113_bb0065","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41577-023-00856-y","article-title":"Targeting IL-6 trans-signalling: past, present and future prospects","volume":"23","author":"Rose-John","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2026.157113_bb0070","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.4049\/jimmunol.1302470","article-title":"Blockade of IL-6 trans signaling attenuates pulmonary fibrosis","volume":"193","author":"Le","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2026.157113_bb0075","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1074\/jbc.M113.545822","article-title":"Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-beta (TGF-beta) signaling promoting SMAD3 activation and fibrosis via gremlin protein","volume":"289","author":"O\u2019Reilly","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2026.157113_bb0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/labinvest.2016.84","article-title":"Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-beta1 signaling pathway","volume":"96","author":"Wang","year":"2016","journal-title":"Lab. Investig."},{"key":"10.1016\/j.cyto.2026.157113_bb0085","article-title":"Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: a subgroup analysis of a global, randomised, controlled phase 3 trial","author":"Kuwana","year":"2023","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.cyto.2026.157113_bb0090","first-page":"7","article-title":"Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis","author":"Roodenrijs","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.cyto.2026.157113_bb0095","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/mol.105.017483","article-title":"Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression","volume":"69","author":"Jinnin","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cyto.2026.157113_bb0100","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2026.157113_bb0105","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2026.157113_bb0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2026.157113_bb0115","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cyto.2026.157113_bb0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/cei.12179","article-title":"Transforming growth factor (TGF)-beta signalling is increased in rheumatoid synovium but TGF-beta blockade does not modify experimental arthritis","volume":"174","author":"Gonzalo-Gil","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2026.157113_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/thoraxjnl-2017-210728","article-title":"JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study","volume":"73","author":"Milara","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.cyto.2026.157113_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s42358-024-00396-6","article-title":"Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study","volume":"64","author":"Qi","year":"2024","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.cyto.2026.157113_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.imlet.2006.02.003","article-title":"Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression","volume":"105","author":"Cho","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2026.157113_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/1874471015666220128113319","article-title":"Interleukin 6 concentration in synovial fluid of patients with inflammatory and degenerative arthritis","volume":"18","author":"Mihailova","year":"2022","journal-title":"Curr. Rheumatol. Rev."},{"key":"10.1016\/j.cyto.2026.157113_bb0145","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/ar2217","article-title":"Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts","volume":"9","author":"Pohlers","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2026.157113_bb0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/s10165-004-0378-2","article-title":"Transforming growth factor beta stimulates rheumatoid synovial fibroblasts via the type II receptor","volume":"15","author":"Bira","year":"2005","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.cyto.2026.157113_bb0155","first-page":"9","article-title":"The roles of post-translational modifications in STAT3 biological activities and functions","author":"Tesoriere","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cyto.2026.157113_bb0160","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.1401779","article-title":"Noncanonical STAT3 activation regulates excess TGF-beta1 and collagen I expression in muscle of stricturing Crohn\u2019s disease","volume":"194","author":"Li","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2026.157113_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12931-020-1319-0","article-title":"TGF-beta pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling","volume":"21","author":"Epstein Shochet","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.cyto.2026.157113_bb0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/abbs\/gmx118","article-title":"Smad3-STAT3 crosstalk in pathophysiological contexts","volume":"50","author":"Itoh","year":"2018","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.cyto.2026.157113_bb0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.biopha.2017.12.035","article-title":"STAT3 aggravates TGF-beta1-induced hepatic epithelial-to-mesenchymal transition and migration","volume":"98","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cyto.2026.157113_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4161\/cc.4.2.1413","article-title":"IL-6 signaling promotes tumor growth in colorectal cancer","volume":"4","author":"Becker","year":"2005","journal-title":"Cell Cycle"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:24:24Z","timestamp":1773959064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"alternative-id":["S1043466626000086"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157113","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6 trans-signaling activates the TGF-\u03b2 pathway via soluble factors in difficult-to-treat rheumatoid arthritis joint fluid","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157113"}}